Future Prospects for Neisseria gonorrhoeae Treatment.

about

Future Prospects for Neisseria gonorrhoeae Treatment.

Item

http://www.wikidata.org/entity/Q55406005

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Future Prospects for Neisseria gonorrhoeae Treatment.

@en

Future Prospects for Neisseria gonorrhoeae Treatment.

@nl

type

Item

label

Future Prospects for Neisseria gonorrhoeae Treatment.

@en

Future Prospects for Neisseria gonorrhoeae Treatment.

@nl

prefLabel

Future Prospects for Neisseria gonorrhoeae Treatment.

@en

Future Prospects for Neisseria gonorrhoeae Treatment.

@nl

P1476

Future Prospects for Neisseria gonorrhoeae Treatment

@en

P2093

Beatriz Suay-García

http://www.w3.org/2001/XMLSchema#string

María Teresa Pérez-Gracia

http://www.w3.org/2001/XMLSchema#string

P2860

Bacteriophage therapy: a potential solution for the antibiotic resistance crisis

High-throughput screening for novel inhibitors of Neisseria gonorrhoeae penicillin-binding protein 2

A meta-analysis of the efficacy of ocular prophylactic agents used for the prevention of gonococcal and chlamydial ophthalmia neonatorum.

Identification of Novel Immunogenic Proteins of Neisseria gonorrhoeae by Phage Display.

In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatm

High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014.

In Vitro Activity of Delafloxacin against Clinical Neisseria gonorrhoeae Isolates and Selection of Gonococcal Delafloxacin Resistance.

A Phase 2 Trial of Oral Solithromycin 1200 mg or 1000 mg as Single-Dose Oral Therapy for Uncomplicated Gonorrhea.

New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae.

In Vitro Activity of Gepotidacin, a Novel Triazaacenaphthylene Bacterial Topoisomerase Inhibitor, against a Broad Spectrum of Bacterial Pathogens.

P31

scholarly article

P356

10.3390/ANTIBIOTICS7020049

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M T Pérez-Gracia

Beatriz Suay

P577

2018-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29914071

http://www.w3.org/2001/XMLSchema#string

P921

Neisseria gonorrhoeae

P932

6022920

http://www.w3.org/2001/XMLSchema#string